Jurors' Answers In FTC's Prevagen Complaint Might Burst A Memory Bubble For Health Claims

“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put a fork in the road of a long dispute between FTC and supplement product manufacturers and marketers.

• Source: Shutterstock

More from Compliance

More from Policy & Regulation